Question 1

What is congenital dyserythropoietic anemia type 3?

Accepted Answer

Congenital dyserythropoietic anemia type 3 (CDA III) is a rare blood disorder that affects red blood cell development, resulting in mild to moderate anemia. Abnormalities in the bone marrow, including the presence of unusually large, multinucleated erythroblasts, are a hallmark of the condition. The disorder is associated with pathogenic variants in the KIF23 gene and is inherited in an autosomal dominant pattern, and it is extremely rare, affecting fewer than 1 in 1,000,000 people.

Question 2

What are the symptoms of congenital dyserythropoietic anemia type 3?

Accepted Answer

Individuals with CDA III typically display laboratory findings such as reduced haptoglobin levels and increased circulating lactate dehydrogenase, reflecting the abnormal production and turnover of red blood cells. These findings often accompany clinical symptoms related to anemia, including fatigue and pallor. Not all individuals experience every feature, and the severity of symptoms can vary considerably.

Question 3

What causes congenital dyserythropoietic anemia type 3?

Accepted Answer

CDA III is caused by pathogenic variants in the KIF23 gene, which plays an essential role in cell division and proper erythropoiesis. The condition is inherited in an autosomal dominant pattern, meaning that a single copy of the altered gene is sufficient to cause the disorder. This also means that each child of an affected individual has a chance of inheriting the variant, and families may benefit from genetic counseling to discuss these implications. Associated genes include KIF23.

Question 4

How is congenital dyserythropoietic anemia type 3 inherited?

Accepted Answer

congenital dyserythropoietic anemia type 3 follows an autosomal dominant inheritance pattern. This means inheriting just one copy of the altered gene from either parent can cause the condition.

Question 5

How rare is congenital dyserythropoietic anemia type 3?

Accepted Answer

congenital dyserythropoietic anemia type 3 is classified as very rare. The estimated prevalence is approximately <1 in 1,000,000. Because rare disease data can be limited, actual numbers may differ from published estimates.

Question 6

How is congenital dyserythropoietic anemia type 3 diagnosed?

Accepted Answer

Diagnosis of CDA III is confirmed through molecular genetic testing that identifies pathogenic variants in the KIF23 gene. In addition to genetic analysis, clinicians evaluate characteristic laboratory findings, such as reduced haptoglobin, increased lactate dehydrogenase, and the presence of multinucleated erythroblasts in bone marrow. Because the clinical features can overlap with other anemic conditions, genetic testing remains essential for an accurate diagnosis.

Question 7

Are there treatments for congenital dyserythropoietic anemia type 3?

Accepted Answer

Currently, management of CDA III focuses on supportive care and symptom management, as there are no FDA-approved treatments specifically linked to the condition. Treatment is tailored to the individual and often involves a multidisciplinary team to monitor health and address symptoms effectively. Patients are encouraged to discuss treatment options with their healthcare team, and genetic counseling can provide additional guidance regarding inheritance and family planning.

Question 8

What complications can arise from congenital dyserythropoietic anemia type 3?

Accepted Answer

Complications from congenital dyserythropoietic anemia type 3 (CDA III) can include severe fatigue and other symptoms related to anemia. Some individuals may also experience more serious issues if their anemia worsens or if they have difficulty managing their symptoms. Regular monitoring and supportive care are important to help prevent complications.

Question 9

How does congenital dyserythropoietic anemia type 3 affect daily life?

Accepted Answer

Living with congenital dyserythropoietic anemia type 3 (CDA III) can mean managing symptoms like fatigue and pallor, which may affect daily activities. Individuals may need to adjust their routines to include more rest or frequent check-ups with healthcare providers. Support from family and friends can also be very helpful in managing daily life with this condition.

Question 10

What is the long-term prognosis for someone with congenital dyserythropoietic anemia type 3?

Accepted Answer

The long-term prognosis for individuals with congenital dyserythropoietic anemia type 3 (CDA III) can vary based on the severity of symptoms and the age at diagnosis. Many people can maintain a stable condition with proper management and care. Ongoing support from healthcare professionals can help improve outcomes over time.

Question 11

Should families consider genetic counseling for congenital dyserythropoietic anemia type 3?

Accepted Answer

Yes, families should consider genetic counseling for congenital dyserythropoietic anemia type 3 (CDA III). Since the condition is inherited in an autosomal dominant pattern, understanding the risks for future children is important. Genetic counselors can provide valuable information about inheritance patterns and help families make informed decisions.

Organ System	Phenotype Count	Example Features
Blood and immune system	3	Anemia of inadequate production, Macrocytic anemia, Congenital hypoplastic anemia
Prenatal/birth	1	Anemia of inadequate production
Lab test results	1	Elevated LDH (tissue damage marker) (increased circulating lactate dehydrogenase concentration)
Digestive system	1	Jaundice
Pregnancy and birth	1	Congenital hypoplastic anemia

Research Type	Count	% of Total
Research summaries	50	56%
Laboratory research	13	14%
Disease patterns and progression	12	13%
Clinical study results	7	8%
Testing and diagnosis research	4	4%
Patient case studies	4	4%

Kisho

congenital dyserythropoietic anemia type 3

Overview

Clinical Presentation

Medical References

External Resources

OMIM

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Explore clinical features

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

congenital dyserythropoietic anemia type 3

Overview

Clinical Presentation

Medical References

External Resources

OMIM

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is congenital dyserythropoietic anemia type 3?

What are the symptoms of congenital dyserythropoietic anemia type 3?

What causes congenital dyserythropoietic anemia type 3?

How is congenital dyserythropoietic anemia type 3 inherited?

How rare is congenital dyserythropoietic anemia type 3?

How is congenital dyserythropoietic anemia type 3 diagnosed?

Are there treatments for congenital dyserythropoietic anemia type 3?

What complications can arise from congenital dyserythropoietic anemia type 3?

How does congenital dyserythropoietic anemia type 3 affect daily life?

What is the long-term prognosis for someone with congenital dyserythropoietic anemia type 3?

Should families consider genetic counseling for congenital dyserythropoietic anemia type 3?

Explore clinical features

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications